Cardio Diagnostics Holdings, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Cardio Diagnostics Holdings, Inc. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $3.69M, a 7.88% increase year-over-year.
- Cardio Diagnostics Holdings, Inc. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $116.65K, a 94.17% decline year-over-year.
- Cardio Diagnostics Holdings, Inc. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $3.42M, a 98.73% increase year-over-year.
- Cardio Diagnostics Holdings, Inc. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $2.00M.
- Cardio Diagnostics Holdings, Inc. stock issued during period, value, new issues for fiscal 2025 was $3.80M, a 69.31% decline from fiscal 2024.
- Cardio Diagnostics Holdings, Inc. stock issued during period, value, new issues for fiscal 2024 was $12.39M.
- Cardio Diagnostics Holdings, Inc. stock issued during period, value, new issues for fiscal 2021 was $1.23M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-03-31 | $3.69M 10-Q · filed 2026-08-07 | |
| 2025-12-31 | $3.80M 10-K · filed 2026-03-13 | |
| 2025-09-30 | $116.65K 10-Q · filed 2025-11-12 | |
| 2025-03-31 | $3.42M 10-Q · filed 2026-08-07 | |
| 2024-12-31 | $12.39M 10-K · filed 2026-03-13 | |
| 2024-09-30 | $2.00M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $1.30M 10-Q · filed 2025-11-12 | |
| 2024-03-31 | $1.72M 10-Q · filed 2025-11-12 | |
| 2021-12-31 | $1.23M 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |